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Royal Jelly (RJ) is widely consumed in diets throughout the world due to its beneficial effects: antioxidant, antitumor and anti-
inflammatory. We have investigated the role of RJ in the development of TNBS colitis in mice. Colitis was induced by a rectal
instillation of TNBS at 0.1mL per mouse. Intestine samples of the animals orally treated with RJ (100, 150, and 200mg/kg) were
collected for antioxidant assays (GSH and GSH-Px), proinflammatory protein quantification (COX-2 and NF-𝜅B), and histological
analyses. RJ 100mg/kg maintained GSH levels and increased the activity of GSH-Px, downregulated key inflammatory mediators
(COX-2 and NF-𝜅B), and decreased the lesions caused by TNBS as shown by the histological analyses. In conclusion, RJ showed
anti-inflammatory and antioxidant properties in experimental colitis, resulting in the amelioration of the macroscopic and
histological analyses. These results corroborate with the RJ supplementation in diets.
1. Introduction
Royal jelly (RJ) is an important functional food item that
possesses several health-promoting properties and has been
widely used in commercial medical products, healthy foods,
and cosmetics in many countries [1]. The myriad effects
accredited toRJ are comprehensible due to its richness in vita-
mins, minerals, proteins, amino acids, and carbohydrates [2].
Some of its accredited properties are immunomodulation [3]
anti-inflammatory [4], healing [5], and antiaging [6]. It is a
nourishing substance secreted by the mandibular and hypo-
pharyngeal glands of worker honey bees Apis mellifera [7].
On one hand, royal jelly is accredited to exert many beneficial
effects to the body; on the other, there are some reports of
anaphylactic shock, allergy, and acute colitis due to its intake
[8–10]. Recently, due to the biological effects accredited to
RJ, its use has been increasing throughout the world, which,
in turn, has been attracting enormous attention from the
scientific community. It is already known that highly reactive
free radicals are formed by either exogenous chemicals or
endogenous metabolic processes of the body.These free radi-
cals are capable of oxidizing biomolecules, resulting in tissue
damage and consequent cell death [11] in various pathological
processes including inflammatory bowel disease [12, 13].
Ulcerative colitis (UC) and Crohn’s disease (CD) are the
twomajor forms of inflammatory bowel diseases (IBD). Both
UC and CD are of complex etiology and are believed to
arise from the interaction of genetic, environmental, and
microbial factors [14]. These two forms of IBD occur in the
large intestine, although CD may affect the whole digestive
tract while UC tends to be restricted to the distal portion of
the tube (rectum) [15]. Either CD or UC presents ulcerated
areas; the first shows a transmural lesion, affecting the entire
wall thickness (from the mucosa to the serosa). The second
is shallower, affecting the mucosal lining only. Many authors
have proposed that these intestinal conditions are mediated
Hindawi Publishing Corporation
e Scientific World Journal
Volume 2015, Article ID 956235, 7 pages
http://dx.doi.org/10.1155/2015/956235
2 The Scientific World Journal
by the activation of both lymphocytes and nonlymphoid cells
such as macrophages and neutrophils. Once a vast number of
these cells are activated, they migrate to the harmed mucosa
site, leading to an overproduction of oxygen free radicals that
may damage or even kill the cells in the inflamed area [16].
The antioxidant and anti-inflammatory mechanisms are
of crucial importance to the homeostasis and integrity of the
bowel. Since scientists have not developed an effective drug
for the IBD treatment yet [9], new and alternative therapies
arise not only as a promise but, rather, as a necessity for
the patients undergoing such conditions. Due to the anti-
inflammatory [4] and antioxidant properties of RJ [1], the
oxidative stress taking place in the intestine of UC and
CD patients, and a study reporting that RJ was effective at
attenuating acetic acid-induced colitis in rats [17], our group
decided to investigate whether an oral pretreatment with RJ
would have any effect on mice submitted to TNBS-induced
colitis.
2. Materials and Methods
2.1. Animals. Unib-SW 6–8-week-old female mice were pur-
chased from CEMIB-UNICAMP. All the protocols used in
this study were in accordance with the Ethics Committee on
the Use of Experimental Animal (CEUA) from UNICAMP
(2398-1). All animals had free access to tap filtered water
and certified rodent chow (Nuvilab) during the whole exper-
iment. Room temperature was kept constant with 12/12 light
dark cycles 60 ± 1% humidity and a temperature of 21 ± 2∘C.
2.2. Drugs, Reagents, and Royal Jelly. All drugs and reagents
were prepared right before use and were of chemical grade.
2,4,6-Trinitrobenzene sulfonic acid (TNBS) and NaCl were
bought from Sigma (MO, USA). Royal Jelly was obtained
from Baldoni apiary (Sa˜o Paulo, Brazil) and solubilized in
saline 0,9% with 5 minute-sonication and heavy agitation in
vortex. Following agitation, the solution was collected and
diluted at test doses (100, 150, and 200mg/kg of animal).
2.3. Experimental Protocols. Mice were randomly assigned
into five groups (𝑛 = 10): noncolitic saline, negative control
group TNBS, in which none received royal jelly and the other
3 groups received, orally, daily for 19 days, 100, 150, and
200mg/kg of royal jelly (suspended in saline 10mL/kg). Both
saline and TNBS groups were given 10mL/kg of saline daily.
Two weeks after pretreatment started, mice from the TNBS
andRJ pretreated groups (100, 150, and 200mg/kg) (Figure 5)
were rendered colitis by the method originally described by
Morris et al. [18]. Briefly, they were anaesthetized with hal-
othane and given 10mg of 2,4,6-trinitrobenzenesulfonic acid
(TNBS) dissolved in 0.1mL of 50% ethanol (v/v) through a
Teflon cannula inserted 4 cm through the anus.Mice from the
noncolitic group were administered intracolonically 0.25mL
of phosphate-buffered saline instead of TNBS. Behavior, body
weight, and stool consistency were recorded daily throughout
the experiment. All mice were killed by cervical dislocation 4
days after induction of colitis and the colon was removed and
placed on cold plate and longitudinally cut into two slices.
2.4. Macroscopic Features of Colitis. The severity of colon dam-
agewasmacroscopically assessed using the criteria previously
established for TNBS-induced colitis [19]. A score ranging
from 0 to 10 was employed, as follows: 0, no damage; 1, hyper-
aemia without ulcers; 2, hyperaemia and wall thickening
without ulcers; 3, one ulceration site without wall thickening;
4, two or more ulceration sites; 5, 0.5 cm extension of
inflammation or major damage; and 6–10, 1 cm extension of
inflammation or severe damage. The score was increased by
1 for every 0.5 cm of damage up to a maximal score of 10; by
0 or 1 for absence or presence of diarrhea and 0, 1, or 2 for
absence, presence of mild or severe adhesion, respectively.
2.5. Histological Features of Colitis. The colon was dissected
and fixed with 4% paraformaldehyde (Merck, Darmstadt,
Germany) in 0.1M phosphate-buffered saline (PBS; pH 7.4)
for 24 h at 4∘C.The tissues of three animals per experimental
group were dehydrated in graded concentrations of alcohol,
embedded in historesin (Leica Microsystems, Heidelberg,
Germany) and sectioned transversely at a width of 2 𝜇m.The
resulting serial sections were mounted on slides, stained with
hematoxylin and Floxin and imaged using a Nikon Eclipse
E800 light microscope. The images were then qualitatively
examined by histopathologists in double-blind experiment.
The qualitative histopathological analysis focused on changes
of the epithelium integrity, oedema, lymphocytic infiltration,
cytoplasmic vacuolization, and necrosis.
2.6. Glutathione Level Determination (GSH). GSH levels of
colonic tissue of animals were determined by Ellman’s reac-
tion using 5󸀠5󸀠-dithiobis-2-nitrobenzoic acid (DTNB) as
described by Anderson [20]. The intensity of the yellow
colour was read at 412 nm.
2.7. Glutathione Peroxidase Activity (GSH-Px). GSH-Px activ-
ity was quantified by following the decrease in absorbance at
365 nm induced by 0.25mMH
2
O
2
in the presence of reduced
glutathione (10mM), NADPH, (4mM), and 1U enzymatic
activity of GSH-Px [21].
2.8. Western Blotting Analyses. Frozen colon samples were
homogenized in 1mL of cold buffer containing phosphate
buffer (PB) 0.1M, pH 7.4, and protease inhibitor cocktail
1% (Sigma-Aldrich P-8340). Homogenates were centrifuged
(12,000×g, 45min, 4∘C) and the supernatants were collected
and stored at −80∘C. Different centrifugation times and
buffers were used for the cytosolic (14,000×g, 45min, 4∘C),
membrane (14,000×g, 45min, 4∘C), and nuclear extracts
(15,000×g, 60min, 4∘C) respectively, according to Helenius
et al. (1996) with modifications [22]. Protein concentration
of the homogenate was determined following Bradford’s col-
orimetric method Bradford [23]. Then, samples were treated
with Laemmli buffer (PB 0.5M, pH 6.8; glycerol, sodium
dodecyl sulfate (SDS) 10%, bromophenol 0.1%, and 𝛽-mer-
captoethanol) [24] in a 1 : 1 proportion. Equal amounts of
protein from samples (70 𝜇g) were separated on 8% acry-
lamide gel by sodiumdodecyl sulfate polyacrylamide gel elec-
trophoresis. In the next step, proteinswere electrophoretically
transferred onto a nitrocellulose membrane and incubated
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Table 1: Effect of royal jelly on the disease activity index of mice
undergoing TNBS-induced colitis.
Group Macroscopicassessment Adhesion Diarrhea
Noncolitic (saline) 0 ± 0b 0 ± 0b 0 ± 0b
Colitic (TNBS) 4.5 ± 0.42 1.5 ± 0.54 0.71 ± 0.48
RJ 100mg/kg 2.56 ± 0.29a 0.44 ± 0.72a 0.67 ± 0.5
RJ 150mg/kg 2.67 ± 0.236a 0.625 ± 0.91 0.62 ± 0.51
RJ 200mg/kg 3.88 ± 0.515 1.38 ± 0.91 0.750 ± 0.46
Results are presented as mean ± SEM. ANOVA followed by Dunnett’s 𝑡-test.
a
𝑃 < 0.05 and b𝑃 < 0.001 are significantly different from colitic nontreated
group.
with specific primary antibodies: COX-2 (160126) (Cayman
Chemical, USA) at 1 : 500 dilution and NF-𝜅B (MAB 2697)
(R&D Systems, USA) at 1 : 2000. Eachmembrane was washed
three times for 10min and incubated with HRP-Goat Anti-
Rabbit (Invitrogen 656120) (COX-2, diluted at 1 : 5000).
To prove equal loading, the blots were analyzed with stan-
dard protein Ponceau dye [24]. Immunodetection was per-
formed using enhanced chemiluminescence light-detecting
kit (SuperSignal West Femto Chemiluminescent Substrate,
Pierce, IL, USA). Densitometric data were performed with
G-BOX, Syngene, following normalization to the control
(Ponceau) by GeneSys software.
2.9. Statistical Analysis. Results were expressed as mean ±
standard error of means (SEM).The statistical significance of
each test group in relation to the control was calculated using
ANOVA followed by Dunnett’s 𝑡-test.
3. Results
3.1. Macroscopic Evaluation of Colitis. Mice subjected to royal
jelly pretreatment showed an overall lower impact of TNBS-
induced colonic damage compared with the TNBS control
group. Macroscopic inspection showed evidence of severe
colonic mucosal damage, with oedema, deep ulcerations,
and hemorrhage in TNBS group. The doses of 100 and
150mg/kg significantly diminished the damage provoked
by the hapten (𝑃 < 0.05) (Table 1). When evaluating the
adhesion parameter only, the dose of 100mg/kg was capable
of preventing its aggravation. The treated mice with RJ (100
and 150mg/kg) showed a faster weight recovery than those
of the TNBS group (Figure 1). However, mice from the TNBS
control group showed a lowerweight recovery throughout the
experiment in comparison with the mice from the noncolitic
group (𝑃 < 0.05). All the other experiments were performed
using only the lowest effective dose.
3.2. Histological Evaluation of Colitis. The effective induction
of TNBS-induced inflammation was corroborated by the loss
of epithelium integrity, oedema, and inflammatory infiltrate
as shown in Figures 2(a)–2(e). Figure 2 summarizes the tissue
damage from all groups, colitic and noncolitic (Saline, TNBS,
RJ 100, 150, and 200mg/kg). Qualitatively, the noncolitic
group saline showed a normal mucosa of the colon with an
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Figure 1: Weight means of the 5 different groups on days 1, 6, and 13
(before induction) and 16 and 19 (after induction). Data is presented
as mean ± SEM. Two-way ANOVA followed by Bonferroni’s 𝑡-test.
∗
𝑃 < 0.05, ∗∗∗𝑃 < 0.001 are significantly different from TNBS
group.
intact simple columnar epitheliumandnumerous goblet cells.
The crypts of Lieberku¨hn are straight and unbranched and
lined largely with goblet cells. The appearance of the lamina
propria is consisted by soft connective tissue, leukocytes, and
the muscularis mucosae. Next, the submucosa of this group
is made of irregular connective and adipose tissue, numerous
blood vessels, and several ganglion cells and nerves of the
submucosal plexus.
However, the TNBS-colitic control group showed an
extensively loss of epithelium integrity (ulceration) and
crypts, loss of goblet cells, and no definite mucosal lining as
well as a great number of inflammatory cells that might indi-
cate necrosis. The RJ 100mg/kg group showed a decreased
number of goblet cells, moderate cell infiltrate, mainly neu-
trophils, and a low intensity oedema when compared with
TNBS colitic group.The RJ 150mg/kg group showed as many
goblet cells as noncolitic group saline and an apparently
better epithelium integrity; on the other hand, the number
of inflammatory cells is qualitatively higher when compared
to RJ 100 group. The RJ 200mg/kg group showed a massive
infiltrate and no delimitations of either the mucosal lining or
epithelium, similarly to the TNBS control group.
3.3. Glutathione Level Determination (GSH). The GSH levels
in the noncolitic group were high and after TNBS colitis
induction the GSH levels drastically reduced; on the other
hand, RJ 100mg/kg was capable of preventing the decrease
in the levels of GSH after colitis induction. Interestingly, the
protection of GSH levels exerted by RJ 100mg/kg was similar
to those of the noncolitic group (Table 2).
3.4. Glutathione Peroxidase Activity (GSH-Px). The nonco-
litic (saline) and colitic (TNBS) groups were the same regard-
ing GSH-Px activity. RJ at the doses of 100mg/kg was able to
increase the activity of GSH-Px (Table 2).
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Figure 2: Representative light microscopy of colons from both colitic and noncolitic groups. Micrographs of the groups saline (a), TNBS (b),
andRJ 100, RJ 150, andRJ 200 receiving both TNBS and royal jelly (c), (d), and (e), respectively. Hematoxylin and Floxin staining.Micrographs
were taken using 10x objective lens. Each image is representative of 3 animals.
Table 2: Effect of royal jelly on colonic GSH level and GSH-Px and
GR activities in TNBS-induced colitis in mice.
Group
Colon GSH levels
(𝜇mol/mg of
protein)
Colon GSH-Px activity
(nmol/min/mg
protein)
Noncolitic (saline) 25.1 ± 5.91a 5.0 ± 0.28
Colitic (TNBS) 8.6 ± 1.10 4.5 ± 0.43
RJ 100mg/kg 22.8 ± 3.11a 11.8 ± 3.18a
RJ 150mg/kg 12.6 ± 3.06 11.0 ± 0.8
RJ 200mg/kg 5.62 ± 2.56 9.0 ± 0.7
Results are presented as mean ± SEM. ANOVA followed by Dunnett’s 𝑡-test.
a
𝑃 < 0.05 is significantly different from TNBS group.
3.5. Western Blotting Analyses. NF-𝜅B and COX-2 from
colonic mucosa were measured by western blotting (Figures
3 and 4).The levels of expression of NF-𝜅B p65 were detected
in low quantity in nuclei of normal mucosa whereas a high
expression of nuclear factor appeared in colon mucosa from
control TNBS colitic group. Nonetheless, upon pretreatment
with RJ 100mg/kg, the expression of NF-𝜅B p65 was kept at
lower levels than TNBS group (Figure 3). As shown in Fig-
ure 4, exposure of colon to TNBS caused strong expression of
COX-2; on the other hand, RJ at 100mg/kg induced down-
regulation of COX-2 when compared with TNBS group (𝑃 <
0.001).
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Figure 3: Representative Western blot analysis of analysis of NF-
𝜅B. Densitometric data were studied following normalization to the
control (Ponceau). The results are representative of three experi-
ments performed on different samples and data are expressed as
mean ± SEM. ANOVA followed by Dunnett’s 𝑡-test. a𝑃 < 0.05 is
significantly different from TNBS group.
4. Discussion
Ulcerative colitis (UC) and Crohn’s disease (CD) are the two
major forms of inflammatory bowel disease (IBD); both dis-
eases share common features, despite differing in the etiology.
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Figure 4: Representative Western blot analysis of COX-2 proteins.
Densitometric data were studied following normalization to the
control (Ponceau). The results are representative of three experi-
ments performed on different samples and data are expressed as
mean ± SEM. ANOVA followed by Dunnett’s 𝑡-test. a𝑃 < 0.05, b𝑃 <
0.01, and c𝑃 < 0.001 are significantly different from TNBS.
These two forms of IBD are characterized by an exacerbated
immune response towards enteric commensal microbial
population [25]. The symptoms are also similar: abdominal
pain, severe diarrhea, bloody feces, and consequent anaemia
and weight loss. Some patients may lose up to 20% of the
total weight in very short periods in the acute phase of the
disease, which can be observed in animal models of experi-
mental colitis. Animal models of intestinal inflammation are
indispensable for our understanding of the pathogenesis of
CD and UC. These models are used to evaluate new anti-
inflammatory strategies. One of the most widely usedmodels
is colitis induced by the hapten TNBS. It is thought that
this model resembles Crohn’s disease because of the resulting
mucosal inflammation mediated by aTh1 response [26].
We have demonstrated that all colitic groups lost weight
after TNBS induction and that the RJ 100mg/kg group
restarted weight gain more quickly than those of the TNBS-
colitic group. One must consider that this parameter alone
does not indicate, by itself, any efficacy of the pretreatment;
however, it gives us an idea of the general state of the animal.
The weight loss can be partially explained by the reduction
in chow consumption (data not shown) and water intake due
to the damage in the colon, which, in turn, causes pain and
intense diarrhea.Themacroscopic evaluation is a very impor-
tant tool when assessing experimental TNBS-induced colitis
since it considers the size of the ulceration; hence, we can
evaluate how damaged the tissue remains [19]. In the TNBS-
colitic group, the lesion area was large and showed extensive
tissue thickening. RJ 100mg/kgwas effective in protecting the
mucosa and keeping the lesion smaller than that of the TNBS
group and also presented better macroscopic scores (Table 1).
The macroscopic score presented by the dose of 200mg/kg
was not different from the TNBS one. Moreover, it is already
known that the royal jelly may exert toxic effects if consumed
in high doses or quantities [7–9]; some studies have already
demonstrated that animals receiving high amounts of royal
jelly presented high death rate due to its toxic effects, which
was corroborated by our results. The mechanisms involving
its toxicity are still not entirely elucidated, although one of
the reasons may be likely to happen due to the presence
of polyphenolic compounds in the RJ, including flavonoids
[27]. Flavonoids present different biological activities such as
antioxidant activity. There is evidence that this compound
presents a dual effect, antioxidant or prooxidant, intimately
depending on its concentration [28]. It is likely that the dose
of 200mg/kg is exerting a prooxidant effect.
Many aspects are involved in the inflammatory process,
such as the oxygen reactive species (ROS), which have already
been demonstrated to modulate the immune response. The
respiration process is mandatory for the life of aerobic
organisms, but it can be harmful due to the formation of ROS.
Despite being considered foes, they play very important roles
in living organisms.These molecules may exert an antibacte-
rial function through protein, DNA, and lipid oxidation: on
the other hand, when they are over produced, they become
a threat to cells, due to their great oxidizing capacity [28].
There are extensive data showing that ROS are important
players in the pathogenesis of IBD. Increased production
of ROS harms the integrity of the epithelial cells, through
an initial inflammatory response. In order to protect tissues
against ROS-triggered injuries, all cells have antioxidant
enzymes, including glutathione peroxidase (GSH-Px) and
radical scavengers such as sulfhydryl compounds GSH [11].
GSH has already been shown to have its level diminished
in experimental colitis [12]. This is part of the first line of
defense against oxidative stress and the pretreatment with
RJ 100mg/kg was capable of increasing the levels of GSH
(Table 2). These data suggest that RJ has the capacity of pro-
tecting intestinal mucosa from injuries, probably by protect-
ing the depletion of this antioxidant barrier. These results
are in accordance with previous studies showing that the RJ
exerts a free radical scavenging activity [10], therefore ame-
liorating the ongoing inflammation.
Recent reports show that the cytosolic GSH-Px activity in
rat colon tissues is altered in response to oxidative stress [29].
GSH-Px is an antioxidant enzyme that helps scavenging and
inactivating H
2
O
2
, thereby protecting tissues from deleteri-
ous damage caused by the peroxide [30].
The activity of GSH-Px appeared reduced in TNBS-colitic
groups (Table 2); this apparently paradox can be explained by
the GSH and H
2
O
2
dependence on the activity of the GSH-
Px. For the TNBS group, the limiting factor is the level of
GSH (very low); on the other hand, for the non-colitic saline
group, the limiting factor is the H
2
O
2
, that is not augmented,
since there is no oxidative stress going on. In both cases, The
RJ 100mg/kg was capable of increasing the level of GSH as
well as the activity of GSH-Px, demonstrating its antioxidant
property (Table 2).
Evidences indicate that NF-𝜅B, a ubiquitously expressed,
proinflammatory eukaryotic transcription factor is important
in the regulation of a broad spectrum of genes in many
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Figure 5: Pretreatment with Royal Jelly (100, 150, and 200mg/kg)
for 14 consecutive days followed by the administration of TNBS
(induction of colitis) on day 15. The following 3 days (16, 17, and 18),
animals received RJ (100, 150, and 200mg/kg) and were sacrificed
on day 19.
physiological and pathological events [31]. NF-𝜅Bp65 protein
is increased in the colonic biopsies of patients with active IBD
and a direct correlation with severity was observed with their
levels [31]. It has also been reported that the expression ofNF-
𝜅B is augmented in experimental IBD [29]. Due to the impor-
tance of NF-𝜅B, not rarely, researchers make huge efforts
in understanding its biology for potential pharmacological
uses. In our experimental model, the NF-𝜅B expression was
shown to be augmented in the TNBS group, corroborating
with reported data [30]. We have also demonstrated that an
increase in the colonic level of NF-𝜅B was inhibited by the
pretreatment with RJ 100mg/kg when compared with TNBS
group (Figure 4). This NF-𝜅B decreased level is an important
parameter in the protection of the gut against chronic TNBS-
induced intestinal inflammation model [32].
Cyclooxygenase-2 (COX-2) is one of various inflam-
matory mediators regulated by NF-𝜅B. The induced form
of COX enzyme is involved in numerous physiological
responses, mainly inflammation, where they catalyze the syn-
thesis of prostaglandins (PGs) from arachidonic acid [33].
Prostaglandin E
2
(PGE
2
) is one of the most important bio-
logically active prostanoids found throughout the gastroin-
testinal tract. Despite the fact that PGE
2
regulatesmany phys-
iological functions of the digestive tract, including mucosal
protection, gastrointestinal secretion, and motility, it is also
implicated in the pathophysiology of IBD [34]. COX-2 is an
inducible inflammatory enzyme induced by growth factors,
proinflammatory cytokines, tumor promoters, and bacterial
toxins and is increased in TNBS-induced colitis [32].There is
sufficient data to support that the inhibition of this enzyme
is beneficial during TNBS-induced colitis [35]. Our results
showed that the TNBS group showed an increased expression
of COX-2 compared with the noncolitic group and that the
dose of RJ 100mg/kg prevented the overexpression of COX-2,
when compared with TNBS group.The expression of COX-2
is regulated by the NF-𝜅B and thus, its inhibition may lead to
a decrease in the expression of COX-2. Karaca et al. [17] have
reported that RJ was capable of reducing the colonic mast cell
infiltration, which may stimulate the production of COX-2
as well [36]. These data together (COX-2 inhibition, NF-𝜅B
inhibition, and that presented by Karaca et al. [17]) accredits
RJ as a potential candidate for the protection against IBD.
5. Conclusion
TNBS-induced colitis is a widely accepted model for IBD
studies, mainly UC and CD. According to the results shown
and the data published, RJ remains as a prominent nutrient.
We demonstrated that oral pretreatment with RJ may be
effective in protecting the mucosa of mice in TNBS-induced
colitis, partly explained by its antioxidant property, which
consequently prevents proinflammatory mediators from
acutely increasing. It is important, nevertheless, to state that
more comprehensive studies need to be carried out in order
to evaluate more parameters involved in different models
of experimental colitis and that the doses of royal jelly intake
must be cautious mainly due to the adverse effects caused by
high doses.
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